PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Medicine, Tor Vergata University, Rome, Italy; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.\', \'Department of Experimental Medicine, Tor Vergata University, Rome, Italy.\', \'Lifebrain srl, Rome, Italy.\', \'Department of Experimental Medicine, Tor Vergata University, Rome, Italy; Tor Vergata University Hospital, Rome, Italy; IFCC Emerging Technologies Division, Milan, Italy.\', \'Department of Experimental Medicine, Tor Vergata University, Rome, Italy; Tor Vergata University Hospital, Rome, Italy. Electronic address: marzianuccetelli@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1521-6616(21)00255-210.1016/j.clim.2021.108918
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 34971839
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all